Intercure Ltd. Shareholder Meeting Approves All Proposals
Ticker: INCR · Form: 6-K · Filed: Dec 30, 2024 · CIK: 1857030
| Field | Detail |
|---|---|
| Company | Intercure Ltd. (INCR) |
| Form Type | 6-K |
| Filed Date | Dec 30, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Intercure shareholders voted YES on all 5 proposals at the Dec 30th meeting.
AI Summary
On December 30, 2024, Intercure Ltd. held its Annual General Meeting of Shareholders where all five proposals presented were approved. These proposals were previously detailed in the Company's Notice and Proxy Statement dated November 25, 2024.
Why It Matters
The approval of all shareholder proposals indicates alignment between management and investors on key company matters, potentially smoothing the path for future strategic initiatives.
Risk Assessment
Risk Level: low — The filing is a routine update on a shareholder meeting and does not contain new financial or operational risks.
Key Players & Entities
- Intercure Ltd. (company) — Registrant
- December 30, 2024 (date) — Date of Annual General Meeting
- November 25, 2024 (date) — Date of Notice and Proxy Statement
FAQ
What was the outcome of the Annual General Meeting of Shareholders for Intercure Ltd. on December 30, 2024?
All five proposals brought before the shareholders at the meeting were approved.
When was the Notice and Proxy Statement regarding the Annual General Meeting of Shareholders issued?
The Notice and Proxy Statement was dated November 25, 2024.
What type of filing is this for Intercure Ltd.?
This is a Form 6-K, a Report of Foreign Private Issuer.
What is the principal executive office address for Intercure Ltd.?
The address is 85 Medinat ha-Yehudim Street, Herzliya, 4676670, Israel.
Does Intercure Ltd. file annual reports under Form 20-F or Form 40-F?
Intercure Ltd. files annual reports under Form 20-F.
Filing Stats: 220 words · 1 min read · ~1 pages · Grade level 11.7 · Accepted 2024-12-30 16:30:29
Filing Documents
- form6-k.htm (6-K) — 15KB
- 0001493152-24-052501.txt ( ) — 16KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INTERCURE LTD. Date: December 30, 2024 /s/ Amos Cohen Amos Cohen Chief Financial Officer